Fidelity SPDR Advertisement
Home > Boards > Free Zone > Industry Specific > 3D Printing Stocks

MDDD Gary, this looks like a scamalicious reverse merger

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DrContango Member Profile
 
Followed By 44
Posts 1,314
Boards Moderated 0
Alias Born 07/10/02
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
Whistleblowers Score a Big Payday -- Update
Mobile's Rise Poses a Riddle for Banks
AT&T Boosts Dividend
U.S. Hot Stocks: Hot Stocks to Watch
Brazilian Shares Rise, Led by Rossi Residencial; Real Weakens Slightly
Oracle Beats Street View for First Time in a Year
Alstom CEO Expects to Settle DOJ Bribery Allegations Very Soon
DrContango   Tuesday, 11/05/13 02:48:25 PM
Re: 3DPrintInvestor post# 752
Post # of 2751 
MDDD

Gary, this looks like a scamalicious reverse merger shell company unless Umicrom is a legitimate player!!!

Doc

(You say 'tomatoh', I say 'tomatah'
You say MDDD, I say MSSD...)




>>Exchange Transaction

On October 29, 2013 (the "Closing Date"), Makism 3D Corp. (f/k/a Advanced Cellular, Inc.), a Nevada corporation (the "Registrant," "Company" or "MDDD") entered into and consummated a voluntary share exchange transaction with Umicron Ltd., a private limited company organized under the laws of England and Wales ("Umicron"), and the shareholders of Umicron ("Selling Shareholders") pursuant to a Stock Exchange Agreement (the "Exchange Agreement") by and among the Company, Umicron, and the Selling Shareholders.

In accordance with the terms of Exchange Agreement, on the Closing Date, the Registrant issued 30,000,000 shares of its common stock to the Selling Shareholders in exchange for 100% of the issued and outstanding capital stock of Umicron (the "Exchange Transaction"). As a result of the Exchange Transaction, the Selling Shareholders acquired approximately 50.67% of our issued and outstanding common stock, Umicron became our wholly-owned subsidiary, and the Registrant acquired the business and operations of Umicron.

Umicron is a manufacturer of consumer and professional level 3-D printers.<<

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist